et_marketsabout 5 hours ago
BULLISH(85%)
hold
Stocks to buy in 2026 for long term: Kalpataru, Aurobindo Pharma among 5 stocks that could give 20-40% return
Read original source+48.2
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
Long-term stock recommendations from reputable brokerages can guide investors seeking sustained growth. The pharma sector is influenced by regulatory approvals, product pipelines, and global demand.
Trading Insight
Bullish for long-term investors, consider staggered accumulation.
Quick check: KALPATPOWR neutral, AUROPHARMA bullish bias (-0.4% 1d).
Key Evidence
- •Kalpataru, Aurobindo Pharma among 5 stocks that could give 20-40% return.
- •Recommendations from top brokerage firms from ETNow and other sources.
- •Stocks recommended for long-term investment in 2026.
- •Risk flag: Market-wide corrections
- •Risk flag: Company-specific execution risks
Affected Stocks
KALPATPOWRKalpataru Projects International
Positive
Recommended by top brokerage firms for long-term investment with 20-40% return potential.
AUROPHARMAAurobindo Pharma
Positive
Recommended by top brokerage firms for long-term investment with 20-40% return potential.
Sectors:pharma
AI-powered analysis by
Anadi Algo News